Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

about

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

Item

http://www.wikidata.org/entity/Q58738703

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@en

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@nl

type

Item

label

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@en

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@nl

prefLabel

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@en

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@nl

P1476

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines

@en

P2093

Kanami Yamazaki

http://www.w3.org/2001/XMLSchema#string

Kentaro Semba

http://www.w3.org/2001/XMLSchema#string

Miwa Tanaka

http://www.w3.org/2001/XMLSchema#string

Mutsumi Okamura

http://www.w3.org/2001/XMLSchema#string

Nachi Namatame

http://www.w3.org/2001/XMLSchema#string

Naomi Tamaki

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Yaguchi

http://www.w3.org/2001/XMLSchema#string

Shingo Dan

http://www.w3.org/2001/XMLSchema#string

Takao Yamori

http://www.w3.org/2001/XMLSchema#string

Takuro Nakamura

http://www.w3.org/2001/XMLSchema#string

P2860

Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma

The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

A novel fusion gene, SYT-SSX4, in synovial sarcoma.

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

Cancer statistics, 2009

The NCI60 human tumour cell line anticancer drug screen

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

P304

35141-35161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.26216

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30416685

http://www.w3.org/2001/XMLSchema#string

P932

6205545

http://www.w3.org/2001/XMLSchema#string